PMEF
COLL icon

Point72 Middle East FZE’s Collegium Pharmaceutical COLL Stock Holding History

Point72 Middle East FZE’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-9,142
Closed -$204K – 1557
2023
Q3 		$204K Buy
+9,142
New +$209K 0.01% 1008
2023
Q2 		– Sell
-5,257
Closed -$126K – 1617
2023
Q1 		$126K Buy
+5,257
New +$139K ﹤0.01% 1054

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Middle East FZE's COLL Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 9,142 shares — an estimated $204K sold.

Point72 Middle East FZE first reported a position in COLL in Q1 2023 and held it in 2 quarters. The position peaked at $204K in Q3 2023. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 9,142 Collegium Pharmaceutical shares in Q4 2023, an estimated $204K.
  • Point72 Middle East FZE first reported a position in Collegium Pharmaceutical in Q1 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Collegium Pharmaceutical position peaked at $204K in Q3 2023.
  • 193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.